Pacira BioSciences (PCRX) Net Margin (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Net Margin of 1.64% for Q1 2026, down 120.0% year-over-year from 8.22% in Q1 2025, and up 97.71% quarter-over-quarter from 0.83% in Q4 2025.
Pacira BioSciences (PCRX) Net Margin (2010 - 2026) Analysis & Trends
Pacira BioSciences' Net Margin history runs 17 years deep, the most recent figure standing at 1.64% for Q1 2026.
- In Q1 2026, Net Margin fell 120.0% year-over-year to 1.64%; the TTM figure through Mar 2026 stood at 0.7% (up 1546.0% YoY), while the FY2025 annual figure was 0.97%, up 1517.0% from the prior year.
- Net Margin for Q1 2026 stood at 1.64%, up from 0.83% in the prior quarter.
- The five-year high for Net Margin was 15.2% in Q2 2023, with the low at 85.11% in Q3 2024.
- The 5-year median for Net Margin is 3.03% (2025), against an average of 0.81%.
- The sharpest annual moves came in 2024 and 2025: Net Margin plunged 9173 bps in 2024, then jumped 8813 bps in 2025.
- Pacira BioSciences' Net Margin stood at 2.05% in 2022, then soared by 569 bps to 13.72% in 2023, then sank by 38 bps to 8.57% in 2024, then plunged by 90 bps to 0.83% in 2025, then surged by 98 bps to 1.64% in 2026.
- Business Quant data shows PCRX's Net Margin at 1.64% in Q1 2026, 0.83% in Q4 2025, and 3.03% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Pacira BioSciences | 945.51 Mn | 694.48 Mn | 148.24 Mn | 2.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.42% |
| Mar 31, 2026 | 1.64% |
| Dec 31, 2025 | 0.83% |
| Sep 30, 2025 | 3.03% |
| Jun 30, 2025 | -2.68% |
| Mar 31, 2025 | 2.85% |
| Dec 31, 2024 | 8.57% |
| Sep 30, 2024 | -85.11% |
| Jun 30, 2024 | 10.61% |
| Mar 31, 2024 | 5.37% |
| Dec 31, 2023 | 13.72% |
| Sep 30, 2023 | 6.62% |
| Jun 30, 2023 | 15.20% |
| Mar 31, 2023 | -12.18% |
| Dec 31, 2022 | 2.05% |
| Sep 30, 2022 | -0.41% |
| Jun 30, 2022 | 11.73% |
| Mar 31, 2022 | 4.32% |
| Dec 31, 2021 | -3.22% |
| Sep 30, 2021 | 13.83% |